BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20453816)

  • 1. Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.
    Dharma Rao T; Park KJ; Smith-Jones P; Iasonos A; Linkov I; Soslow RA; Spriggs DR
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):462-72. PubMed ID: 20453816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation.
    Nemieboka B; Sharma SK; Rao TD; Edwards KJ; Yan S; Wang P; Ragupathi A; Piersigilli A; Spriggs DR; Lewis JS
    Nucl Med Biol; 2020; 86-87():9-19. PubMed ID: 32403071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.
    Aithal A; Junker WM; Kshirsagar P; Das S; Kaur S; Orzechowski C; Gautam SK; Jahan R; Sheinin YM; Lakshmanan I; Ponnusamy MP; Batra SK; Jain M
    PLoS One; 2018; 13(4):e0193907. PubMed ID: 29708979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
    Rao TD; Tian H; Ma X; Yan X; Thapi S; Schultz N; Rosales N; Monette S; Wang A; Hyman DM; Levine DA; Solit D; Spriggs DR
    PLoS One; 2015; 10(5):e0126633. PubMed ID: 25965947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of binding epitopes of CA125 monoclonal antibodies.
    Marcos-Silva L; Narimatsu Y; Halim A; Campos D; Yang Z; Tarp MA; Pereira PJ; Mandel U; Bennett EP; Vakhrushev SY; Levery SB; David L; Clausen H
    J Proteome Res; 2014 Jul; 13(7):3349-59. PubMed ID: 24850311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope.
    Argüeso P; Spurr-Michaud S; Russo CL; Tisdale A; Gipson IK
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2487-95. PubMed ID: 12766047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies.
    Tu HF; Wong M; Tseng SH; Ingavat N; Olczak P; Notarte KI; Hung CF; Roden RBS
    J Ovarian Res; 2024 Jan; 17(1):19. PubMed ID: 38225646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.
    Rao TD; Fernández-Tejada A; Axelrod A; Rosales N; Yan X; Thapi S; Wang A; Park KJ; Nemieboka B; Xiang J; Lewis JS; Olvera N; Levine DA; Danishefsky SJ; Spriggs DR
    ACS Chem Biol; 2017 Aug; 12(8):2085-2096. PubMed ID: 28617578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for antibody recognition of the proximal MUC16 ectodomain.
    Lee K; Perry K; Xu M; Veillard I; Kumar R; Rao TD; Rueda BR; Spriggs DR; Yeku OO
    J Ovarian Res; 2024 Feb; 17(1):41. PubMed ID: 38374055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene.
    Yin BW; Dnistrian A; Lloyd KO
    Int J Cancer; 2002 Apr; 98(5):737-40. PubMed ID: 11920644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of a monoclonal antibody to the cytoplasmic tail of MUC16.
    Gipson IK; Mandel U; Menon B; Michaud S; Tisdale A; Campos D; Clausen H
    Glycobiology; 2017 Oct; 27(10):920-926. PubMed ID: 28673046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MUC16: The Novel Target for Tumor Therapy].
    Gao R; Lou N; Han X; Shi Y
    Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):452-459. PubMed ID: 35899441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells.
    Lakshmanan I; Ponnusamy MP; Das S; Chakraborty S; Haridas D; Mukhopadhyay P; Lele SM; Batra SK
    Oncogene; 2012 Feb; 31(7):805-17. PubMed ID: 21785467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.
    Felder M; Kapur A; Gonzalez-Bosquet J; Horibata S; Heintz J; Albrecht R; Fass L; Kaur J; Hu K; Shojaei H; Whelan RJ; Patankar MS
    Mol Cancer; 2014 May; 13():129. PubMed ID: 24886523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving role of MUC16 (CA125) in the transformation of ovarian cells and the progression of neoplasia.
    Giamougiannis P; Martin-Hirsch PL; Martin FL
    Carcinogenesis; 2021 Apr; 42(3):327-343. PubMed ID: 33608706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer.
    Thomas D; Sagar S; Liu X; Lee HR; Grunkemeyer JA; Grandgenett PM; Caffrey T; O'Connell KA; Swanson B; Marcos-Silva L; Steentoft C; Wandall HH; Maurer HC; Peng XL; Yeh JJ; Qiu F; Yu F; Madiyalakan R; Olive KP; Mandel U; Clausen H; Hollingsworth MA; Radhakrishnan P
    Mol Ther; 2021 Apr; 29(4):1557-1571. PubMed ID: 33359791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.
    Wang Y; Cheon DJ; Lu Z; Cunningham SL; Chen CM; Luo RZ; Xing D; Orsulic S; Bast RC; Behringer RR
    Differentiation; 2008 Dec; 76(10):1081-92. PubMed ID: 18637025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer.
    Crawford A; Haber L; Kelly MP; Vazzana K; Canova L; Ram P; Pawashe A; Finney J; Jalal S; Chiu D; Colleton CA; Garnova E; Makonnen S; Hickey C; Krueger P; DelFino F; Potocky T; Kuhnert J; Godin S; Retter MW; Duramad P; MacDonald D; Olson WC; Fairhurst J; Huang T; Martin J; Lin JC; Smith E; Thurston G; Kirshner JR
    Sci Transl Med; 2019 Jun; 11(497):. PubMed ID: 31217340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.
    Gubbels JA; Belisle J; Onda M; Rancourt C; Migneault M; Ho M; Bera TK; Connor J; Sathyanarayana BK; Lee B; Pastan I; Patankar MS
    Mol Cancer; 2006 Oct; 5(1):50. PubMed ID: 17067392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A binding domain on mesothelin for CA125/MUC16.
    Kaneko O; Gong L; Zhang J; Hansen JK; Hassan R; Lee B; Ho M
    J Biol Chem; 2009 Feb; 284(6):3739-49. PubMed ID: 19075018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.